Skip to main content

Advertisement

SpringerLink
Log in

Nutritional advice to breast cancer survivors

  • Meeting Highlights
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

Breast cancer (BC) survivors are constantly increasing, and research investment for the identification of modifiable factors associated with BC recurrences is increasing too. The Western lifestyle, characterized by low levels of physical activity and a diet rich in refined carbohydrates, animal fats, and protein, is associated with high prevalence of metabolic syndrome, insulin resistance, and high serum levels of sex hormones and growth factors.

Discussion

The present work summarizes the association between all these metabolic and hormonal factors with the risk of BC and BC recurrences. Since metabolic syndrome and endocrine imbalance may be favorably modified through comprehensive change in lifestyle, dietary changes should be recommended both for BC prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington

    Google Scholar 

  2. Berrino F, Villarini A, De Petris M, Raimondi M, Pasanisi P (2006) Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci 1089:110–118. doi:10.1196/annals.1386.023

    Article  CAS  PubMed  Google Scholar 

  3. Vona-Davis L, Howard-McNatt M, Rose DP (2007) Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev 8:395–408. doi:10.1111/j.1467-789X.2007.00396.x

    Article  CAS  PubMed  Google Scholar 

  4. Vainio H, Bianchini F (2002) Weight control and physical activity. IARC Handbooks of cancer prevention, vol 6. IARC, Lyon

    Google Scholar 

  5. Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762–771. doi:10.1002/ijc.20315

    Article  CAS  PubMed  Google Scholar 

  6. Baer HJ, Colditz GA, Rosner B et al (2005) Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 7:R314–R325. doi:10.1186/bcr998

    Article  PubMed  Google Scholar 

  7. Tehard B, Kaaks R, Clavel-Chapelon F (2005) Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study. Br J Cancer 92:2042–2048. doi:10.1038/sj.bjc.6602620

    Article  CAS  PubMed  Google Scholar 

  8. Lahmann PH, Schulz M, Hoffmann K et al (2005) Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer 93:582–589. doi:10.1038/sj.bjc.6602763

    Article  CAS  PubMed  Google Scholar 

  9. Berclaz G, Li S, Price KN et al (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875–884. doi:10.1093/annonc/mdh222

    Article  CAS  PubMed  Google Scholar 

  10. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638. doi:10.1056/NEJMoa021423

    Article  PubMed  Google Scholar 

  11. Dawood S, Broglio K, Gonzalez-Angulo AM et al (2008) Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14:1718–1725. doi:10.1158/1078-0432.CCR-07-1479

    Article  PubMed  Google Scholar 

  12. Griggs JJ, Sabel MS (2008) Obesity and cancer treatment: weighing the evidence. J Clin Oncol 26:4060–4062. doi:10.1200/JCO.2008.17.4250

    Article  PubMed  Google Scholar 

  13. Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23:1370–1378. doi:10.1200/JCO.2005.01.079

    Article  PubMed  Google Scholar 

  14. Chlebowski RT, Blackburn GL, Thomson CA et al (2006) Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women’s Intervention Nutrition Study. J Natl Cancer Inst 98:1767–1776

    PubMed  Google Scholar 

  15. Litton JK, Gonzalez-Angulo AM, Warneke CL et al (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26:4072–4077. doi:10.1200/JCO.2007.14.4527

    Article  PubMed  Google Scholar 

  16. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327–1334

    CAS  PubMed  Google Scholar 

  17. Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR (1986) Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7:23–30. doi:10.1007/BF01886732

    Article  CAS  PubMed  Google Scholar 

  18. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D (2000) Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75–93

    CAS  PubMed  Google Scholar 

  19. Creighton CJ, Casa A, Lazard Z et al (2008) Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26:4078–4085. doi:10.1200/JCO.2007.13.4429

    Article  CAS  PubMed  Google Scholar 

  20. Griggs JJ, Sorbero ME, Lyman GH (2005) Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 165:1267–1273. doi:10.1001/archinte.165.11.1267

    Article  PubMed  Google Scholar 

  21. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17:2078–2086. doi:10.1158/1055-9965.EPI-08-0206

    Article  CAS  PubMed  Google Scholar 

  22. Eliassen AH, Missmer SA, Tworoger SS et al (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415

    Article  CAS  PubMed  Google Scholar 

  23. Kaaks R, Rinaldi S, Key TJ et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071–1082. doi:10.1677/erc.1.01038

    Article  CAS  PubMed  Google Scholar 

  24. Kaaks R, Berrino F, Key T et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755–765

    CAS  PubMed  Google Scholar 

  25. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616

    CAS  PubMed  Google Scholar 

  26. Micheli A, Muti P, Secreto G et al (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112:312–318. doi:10.1002/ijc.20403

    Article  CAS  PubMed  Google Scholar 

  27. Rock CL, Flatt SW, Laughlin GA et al (2008) Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 17:614–620. doi:10.1158/1055-9965.EPI-07-0761

    Article  CAS  PubMed  Google Scholar 

  28. Roy V, Perez EA (2006) New therapies in the treatment of breast cancer. Semin Oncol 33:S3–S8. doi:10.1053/j.seminoncol.2006.03.018

    Article  CAS  PubMed  Google Scholar 

  29. Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502. doi:10.1002/ijc.20582

    Article  CAS  PubMed  Google Scholar 

  30. Micheli A, Meneghini E, Secreto G et al (2007) Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 25:2685–2690. doi:10.1200/JCO.2006.09.0118

    Article  CAS  PubMed  Google Scholar 

  31. Verheus M, Peeters PH, Rinaldi S et al (2006) Serum C-peptide levels and breast cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 119:659–667. doi:10.1002/ijc.21861

    Article  CAS  PubMed  Google Scholar 

  32. Gunter MJ, Hoover DR, Yu H et al (2009) Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101:48–60. doi:10.1093/jnci/djn415

    CAS  PubMed  Google Scholar 

  33. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605–625. doi:10.1007/BF00051703

    Article  CAS  PubMed  Google Scholar 

  34. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, Jong-Bakker M, Nooijen WJ (1992) Insulin resistance and breast-cancer risk. Int J Cancer 52:511–516. doi:10.1002/ijc.2910520402

    Article  CAS  PubMed  Google Scholar 

  35. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51. doi:10.1200/JCO.20.1.42

    Article  CAS  PubMed  Google Scholar 

  36. Conover CA (1996) Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43(Suppl):S43–S48. doi:10.1507/endocrj.43.Suppl_S43

    Article  CAS  PubMed  Google Scholar 

  37. Dickson R (1996) Biochemical control of breast development. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the breast. Lippincott-Raven, Philadelphia, pp 15–25

    Google Scholar 

  38. Stewart CE, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005–1026

    CAS  PubMed  Google Scholar 

  39. Oh JS, Kucab JE, Bushel PR et al (2002) Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 4:204–217. doi:10.1038/sj.neo.7900229

    Article  CAS  PubMed  Google Scholar 

  40. Baxter RC, Butt AJ, Schedlich LJ, Martin JL (2000) Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. Growth Horm IGF Res 10(Suppl A):S10–S11

    Article  PubMed  Google Scholar 

  41. Norat T, Dossus L, Rinaldi S et al (2007) Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61:91–98. doi:10.1038/sj.ejcn.1602494

    Article  CAS  PubMed  Google Scholar 

  42. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG (2007) Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 16:763–768. doi:10.1158/1055-9965.EPI-06-0960

    Article  CAS  PubMed  Google Scholar 

  43. Campagnoli C, Pasanisi P, Peris C, Berrino F (2008) Insulin-like growth factor-I and breast cancer: epidemiological and clinical data. In: Pasqualini JR (ed) Breast cancer: prognosis, treatment and prevention, 2nd edn. INFORMA-Healthcare, Paris

    Google Scholar 

  44. Rinaldi S, Toniolo P, Muti P et al (2005) IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev 14:493–496. doi:10.1097/00008469-200512000-00001

    Article  PubMed  Google Scholar 

  45. Pasanisi P, Venturelli E, Morelli D, Fontana L, Secreto G, Berrino F (2008) Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 17:1719–1722. doi:10.1158/1055-9965.EPI-07-0654

    Article  CAS  PubMed  Google Scholar 

  46. Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575–581. doi:10.2337/diacare.26.3.575

    Article  PubMed  Google Scholar 

  47. Moller DE, Kaufman KD (2005) Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56:45–62. doi:10.1146/annurev.med.56.082103.104751

    Article  CAS  PubMed  Google Scholar 

  48. Beji NK, Reis N (2007) Risk factors for breast cancer in Turkish women: a hospital-based case-control study. Eur J Cancer Care (Engl) 16:178–184. doi:10.1111/j.1365-2354.2006.00711.x

    Article  CAS  Google Scholar 

  49. Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF (2002) A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44:127–138. doi:10.1207/S15327914NC4402_02

    Article  PubMed  Google Scholar 

  50. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160

    CAS  PubMed  Google Scholar 

  51. Goodwin PJ, Boyd NF, Hanna W et al (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284–292

    Article  CAS  PubMed  Google Scholar 

  52. Han C, Zhang HT, Du L et al (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 26:9–24. doi:10.1385/ENDO:26:1:019

    Article  Google Scholar 

  53. Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268:19–24. doi:10.1007/s11010-005-2993-4

    Article  CAS  PubMed  Google Scholar 

  54. Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11:1361–1368

    CAS  PubMed  Google Scholar 

  55. Peeters PH, van Noord PA, Hoes AW, Fracheboud J, Gimbrere CH, Grobbee DE (2000) Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens 18:249–254. doi:10.1097/00004872-200018030-00002

    Article  CAS  PubMed  Google Scholar 

  56. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34:320–325

    CAS  PubMed  Google Scholar 

  57. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V (2009) Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case–control study. Nutr Metab Cardiovasc Dis (in press)

  58. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238. doi:10.1002/ijc.21812

    Article  CAS  PubMed  Google Scholar 

  59. Goodwin PJ, Ennis M, Bahl M et al (2009) High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat 114:517–525. doi:10.1007/s10549-008-0019-0

    Article  CAS  PubMed  Google Scholar 

  60. Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42:636–647. doi:10.1136/bjsm.2006.029132

    Article  CAS  PubMed  Google Scholar 

  61. Monninkhof EM, Elias SG, Vlems FA et al (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18:137–157. doi:10.1097/01.ede.0000251167.75581.98

    Article  PubMed  Google Scholar 

  62. Peters TM, Schatzkin A, Gierach GL et al (2009) Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 18:289–296. doi:10.1158/1055-9965.EPI-08-0768

    Article  CAS  PubMed  Google Scholar 

  63. Kellen E, Vansant G, Christiaens MR, Neven P, Van Limbergen E (2009) Lifestyle changes and breast cancer prognosis: a review. Breast Cancer Res Treat 114:13–22. doi:10.1007/s10549-008-9990-8

    Article  PubMed  Google Scholar 

  64. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486. doi:10.1001/jama.293.20.2479

    Article  CAS  PubMed  Google Scholar 

  65. Holick CN, Newcomb PA, Trentham-Dietz A et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379–386. doi:10.1158/1055-9965.EPI-07-0771

    Article  PubMed  Google Scholar 

  66. Abrahamson PE, Gammon MD, Lund MJ et al (2006) Recreational physical activity and survival among young women with breast cancer. Cancer 107:1777–1785. doi:10.1002/cncr.22201

    Article  PubMed  Google Scholar 

  67. Enger SM, Bernstein L (2004) Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 90:2138–2141

    CAS  PubMed  Google Scholar 

  68. Pierce JP, Stefanick ML, Flatt SW et al (2007) Greater survival after breast cancer in physically active women with high vegetable–fruit intake regardless of obesity. J Clin Oncol 25:2345–2351. doi:10.1200/JCO.2006.08.6819

    Article  PubMed  Google Scholar 

  69. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC (2009) Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 18:11–27. doi:10.1158/1055-9965.EPI-08-0756

    Article  CAS  PubMed  Google Scholar 

  70. Thiebaut AC, Kipnis V, Schatzkin A, Freedman LS (2008) The role of dietary measurement error in investigating the hypothesized link between dietary fat intake and breast cancer—a story with twists and turns. Cancer Invest 26:68–73. doi:10.1080/07357900701527918

    Article  CAS  PubMed  Google Scholar 

  71. Rock CL, Demark-Wahnefried W (2002) Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 20:3302–3316. doi:10.1200/JCO.2002.03.008

    Article  PubMed  Google Scholar 

  72. Holm LE, Nordevang E, Hjalmar ML, Lidbrink E, Callmer E, Nilsson B (1993) Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst 85:32–36. doi:10.1093/jnci/85.1.32

    Article  CAS  PubMed  Google Scholar 

  73. Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC (1999) Dietary factors and the survival of women with breast carcinoma. Cancer 86:826–835. doi:10.1002/(SICI)1097-0142(19990901)86:5<826::AID-CNCR19>3.0.CO;2-0

    Article  CAS  PubMed  Google Scholar 

  74. Pierce JP, Natarajan L, Caan BJ et al (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289–298. doi:10.1001/jama.298.3.289

    Article  CAS  PubMed  Google Scholar 

  75. Gold EB, Pierce JP, Natarajan L et al (2009) Dietary pattern influences breast cancer prognosis in women without hot flashes: the Women’s Healthy Eating and Living Trial. J Clin Oncol 27:352–359. doi:10.1200/JCO.2008.16.1067

    Article  CAS  PubMed  Google Scholar 

  76. Berrino F, Bellati C, Secreto G et al (2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 10:25–33

    CAS  PubMed  Google Scholar 

  77. Kaaks R, Bellati C, Venturelli E et al (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57:1079–1088. doi:10.1038/sj.ejcn.1601647

    Article  CAS  PubMed  Google Scholar 

  78. Serra-Majem L, Roman B, Estruch R (2006) Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64:S27–S47. doi:10.1111/j.1753-4887.2006.tb00232.x

    Article  PubMed  Google Scholar 

  79. Esposito K, Marfella R, Ciotola M et al (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440–1446. doi:10.1001/jama.292.12.1440

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1, 20133, Milan, Italy

    Patrizia Pasanisi, Anna Villarini, Eleonora Bruno, Milena Raimondi, Giuliana Gargano & Franco Berrino

Authors
  1. Patrizia Pasanisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Villarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eleonora Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milena Raimondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giuliana Gargano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Franco Berrino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrizia Pasanisi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pasanisi, P., Villarini, A., Bruno, E. et al. Nutritional advice to breast cancer survivors. Support Care Cancer 18 (Suppl 2), 29–33 (2010). https://doi.org/10.1007/s00520-009-0701-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-009-0701-8

Keywords

Search

Navigation